Irradiated tumors release danger signals that trigger dendritic cells (DC) activation, as well as a dose-dependent increase in MHC class I presentation leading to tumor recognition, resulting in a higher anti-tumor CD8-T lymphocyte infiltration and cytotoxicity. This evidence concerns the gene CD8A and neoplasm.